[1] 向光大. 胰岛素抵抗与血管内皮功能 [J]. 中华糖尿病杂志 2005.doi:10.3321/j.issn:1006-6187.2005.05.001
[2] Radwan DA, Al-Tahhan MA, Hussein AG. Adipenectin and some inflammatory and endothelial markers in type-2 diabetes with and without cardiovascular disease [J]. Egyptian Journal of Immunology 2005, 12(01).
[3] Celermajer DS, Sorensen KE, Gooch VM. Non-invasiredetection of endothelial dysfuntion in children and adults at risk of atherosclemsis [J]. The Lancet 1992, 340.
[4] Sourij H, Zweiker R, Wascher TC. Effects of pinglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes [J]. DIABETES CARE 2006, 29(05).
[5] Cosentino F, Eto M, De Paolis P. High glucose causes upregulation of eyclooxygenase-2 and ahem prostanoid profile in human endothelial cells:role of protein kinase C an d reactive oxygen speies [J]. Circulation 2003, 107.
[6] Labbate A. Large and micro coronary vascular involvement in diabetes [J]. PhaJ Tuacol Rep 2005, 57.
[7] King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications [J]. Histocbem Cell Biol 2004, 122.
[8] Kim J, Montagnani M, Koh KK. Reciprocal relationships between insulin resistance and endothelial dvsfunction:molecular and pathophysioiogical mechanisms [J]. Circulation 2006, 113.
[9] Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, DeFronzo RA, Kahn CR, Mandarino LJ. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. [J]. The Journal of Clinical Investigation: The Official Journal of the American Society for Clinical Investigation 2000, 3(3).
[10] Maegawa H, Nishio Y, Nakao K, Ugi S, Maeda K, Uzu T, Kashiwagi A. [J]. Endocrine journal 2007.
[11] Sourij H, Zweiker R, Wascher TC. [J]. Diabetes care 2006.
[12] Werner C, Kamani CH, Gensch C, Bohm M, Laufs U. [J]. Diabetes: A Journal of the American Diabetes Association 2007. |
